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AbstrAct
Objectives There is an ongoing debate on the possible 
association between infections in early childhood and 
subsequent cancer risk, but it remains unclear if a 
hospital admission for infection is associated with risk of 
childhood cancer diagnosis. We examined if a hospital-
based diagnosis of pneumonia was a clinical marker of 
the three most common childhood cancers.
Design Population-based cohort study.
setting Denmark, hospital diagnoses, 1994–2013.
Methods Using national health registries, we compared 
the observed incidence of leukaemia, lymphoma and 
brain cancer among 83 935 children with a hospital-
based pneumonia diagnosis with that expected among 
children in the general population. We calculated 
absolute cancer risks and standardised incidence ratios 
(SIRs) as a measure of relative risk.
results The cancer SIRs were substantially increased 
during the first 6 months of follow-up; lymphoid 
leukaemia: 6.2 (95% CI 3.5 to 10.3); myeloid leukaemia: 
14.8 (95% CI 6.0 to 30.6); Hodgkin’s lymphoma: 60.8 
(95% CI 26.2 to 120), non-Hodgkin’s lymphoma: 15.9 
(95% CI 5.2 to 37.2) and brain cancer: 4.4 (95% CI 
1.9 to 8.7). The 6-month absolute risks of leukaemia, 
lymphoma and brain cancer were all low, reaching 
0.05% when combined. An increased risk persisted 
beyond 5 years for non-Hodgkin’s lymphoma and brain 
cancer. However, the 5-year absolute cancer risk was 
0.14%.
conclusions The short-term incidence of leukaemia, 
lymphoma and brain cancer was higher than expected and 
persisted beyond 5 years for non-Hodgkin’s lymphoma and 
brain cancer. However, the absolute cancer risk was low.
IntrODuctIOn 
Presenting signs of cancer in children 
may be vague and overlap with those of 
common childhood conditions. While 
the disease course for leukaemia is often 
short, the symptoms of brain cancer may 
present already 2 years before diagnosis.1 
General practitioners (GPs) are often 
essential in the early diagnostic pathways,2 
but it is plausible that cancer in some 
children debut with acute clinical disease 
necessitating hospitalisation. Hospital 
admission for infection is not clearly asso-
ciated with risk of childhood cancer. Some 
studies have shown that overall there is no 
association with previous admission for 
infectious diseases and risk of leukaemia,3 
while others have found that children 
with common infections requiring hospi-
talisation potentially have a 50% higher 
risk of a subsequent leukaemia diagnosis.4 
Specifically, a hospital diagnosis of pneu-
monia may be associated with subsequent 
increased risk of a leukaemia diagnosis.5 
Pneumonia is a frequent cause of commu-
nity-acquired infection leading to hospital 
contact (annual incidence is up to 40 per 
10 000)6; therefore, any association with 
cancer could be clinically relevant. If abso-
lute cancer risks in children with a hospi-
tal-based diagnosis of pneumonia are high, 
then this could have implications for the 
diagnostic approach in these children.
We assessed absolute and relative risks of 
the three most common childhood cancers, 
leukaemia, lymphoma and brain cancer7 
subsequent to a first hospital-based diag-
nosis of pneumonia.
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strengths and limitations of this study
 ► We performed a population-based study using a 
well-established method to calculate cancer risk, 
estimating both absolute and relative risks.
 ► We focused on hospital-based pneumonia diagnosis 
rather than a composite of infections.
 ► We could not separate the order of diagnoses among 
those diagnosed with pneumonia and cancer during 
same admission.
 ► We did not have information from the medical files 
and therefore could not depict if some children 
were initially misdiagnosed as pneumonia and later 
diagnosed with mediastinal lymphoma.
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Table 1 Risk of leukaemia, lymphoma and brain cancer, 
stratified analysis
n O/E SIR (95% CI)
All 83 935 168/90 1.9 (1.6 to 2.2)
  Boys 47 650 89/53 1.7 (1.3 to 2.1)
  Girls 36 285 79/37 2.2 (1.7 to 2.7)
Age
  0–4 70 476 135/76 1.8 (1.5 to 2.1)
  5–9 8145 14/8 1.7 (0.9 to 2.8)
  10–14 3114 8/3 2.3 (1.0 to 4.5)
  15–17 2200 11/3 4.2 (2.1 to 7.5)
Previous hospitalisations
  0 18 114 20/17 1.2 (0.7 to 1.9)
  1 45 161 94/50 1.9 (1.5 to 2.3)
  2 11 953 24/14 1.8 (1.1 to 2.6)
  3+ 8707 30/10 3.1 (2.1 to 4.4)
Calendar period
  1994–1998 21 618 96/81 1.2 (1.0 to 1.4)
  1999–2003 21 067 61/49 1.3 (1.0 to 1.6)
  2004–2008 20 644 54/29 1.9 (1.4 to 2.5)
  2009–2013 20 607 30/12 2.5 (1.7 to 3.5)
Congenital malformations
  Yes 8733 31*/9 3.7 (2.5 to 5.2)
  Down syndrome 489 9/1 16.2 (7.4 to 30.8)
  No 75 202 137/81 1.7 (1.4 to 2.0)
Immune deficiency
  Yes 137 2/0.1 17.5 (2.1 to 63.2)
  No 83 798 166/90 1.9 (1.6 to 2.2)
Imaging examination (after 2002)
  Yes 36 230 66/25 2.7 (2.1 to 3.4)
  No 13 280 9/8 1.1 (0.5 to 2.1)
Congenital malformations included conditions related to the 
nervous system (Q00-Q07); eye, ear, face and neck (Q10-Q18); 
the circulatory system (Q20-Q28); the respiratory system 
(Q30-Q34); cleft lip and cleft palate (Q35-Q37); the digestive 
system (Q38-Q45); genital organs (Q50-Q56); the urinary system 
(Q60-Q64); malformations and deformations of the musculoskeletal 
system (Q65-Q79) and other (Q80-Q99).
O/E, observed/expected number of cancer; SIR, standardised 
incidence ratio.
MAterIAls AnD MethODs
The source population for this registry-based cohort 
was all Danish children aged 0–17 years who were 
alive between 1994 and 2013 (n=2 884 552). Access to 
medical care including hospital admissions is free of 
charge (tax paid). The Danish National Patient Registry 
(DNPR) captures all contacts with Danish hospitals,8 
and records discharge diagnosis using the Interna-
tional Classification of Diseases (currently the 10th 
revision). The Danish Cancer Registry (DCR) records 
incident cancers in Denmark using ICD-10 and ICD-0–3 
morphology codes.9
We identified all children with a first-time hospital-based 
(inpatient, outpatient clinic and emergency room) 
diagnosis of pneumonia recorded in the DNPR during 
1994–2013. We linked these cases to the DCR (using a 
unique personal identification) to identify incident 
cancers, and then to exclude children with previous 
cancer diagnoses. Owing to the low cancer incidence in 
the cohort, we had sufficient sample size to estimate only 
the risks of the three most common childhood cancers. 
We used information on registrations of chest imaging 
during hospitalisation (recorded since 2002) to examine 
the proportion of imaging-confirmed pneumonia diag-
noses. We obtained information from the DNPR on prev-
alent diagnoses of immune deficiencies and congenital 
diseases, including Down syndrome. We searched for 
hospitalisations before pneumonia diagnosis to elucidate 
the extent of previous hospital contacts. All codes used 
in the study are provided in the online supplementary 
appendix.
statistical analysis
The children were followed for the occurrence of cancer 
from the date of the pneumonia diagnosis until death, 
emigration or end of follow-up 30 November 2013. We 
computed the absolute cancer risk at 6 months and 5 
years following the pneumonia diagnosis.
We compared the observed cancer incidence among 
children with pneumonia with that expected among 
children in the general population (based on national 
cancer incidence rates by age, sex and calendar year). 
Standardised incidence ratios (SIRs) were calculated as 
a measure of relative risk. We computed SIRs for acute 
myeloid leukaemia, acute lymphoid leukaemia, Hodgkin 
lymphoma, non-Hodgkin’s lymphoma and brain cancer. 
Follow-up was divided into first 6 months, 6 months to 5 
years and 5+ years. We stratified the patients by gender, 
age, calendar period and prevalent disease to examine its 
potential impact on cancer risk.
All statistical analyses were conducted using the SAS 
statistical software package V.9.2 (SAS Institute).
results
Patient characteristics
We followed 83 935 children with pneumonia and no 
previous cancer diagnosis for a median of 10 years. The 
incidence of pneumonia diagnosis was stable over the 
20-year period. In the cohort as a whole, 47 650 (57%) 
were boys, and median age was 1.5 years. Pneumonia 
diagnosis was made during an inpatient stay among 
89%, during an outpatient clinic visit in 6% and in the 
emergency room in 5% of the children. Pneumonia was 
registered as the main condition leading to hospitalisa-
tion for 69 479 (83%) children. Of the 49 510 children 
diagnosed with pneumonia after 2002, 36 230 (73%) had 
chest imaging performed during their hospital contact. 
Pneumonia was registered as caused by bacteria in 
14% and by viruses in 22% of children in the study 
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Table 2 Risk of leukaemia, lymphoma and brain cancer by follow-up interval 
Observed/expected numbers of cancer and SIRs (95% CI)
0–<6 months of follow-up 6 months–<5 years 5+ years
Lymphoid leukaemia* 15/2 6.2 (3.5 to 10.3) 27/16 1.7 (1.1 to 2.4) 8/10 0.8 (0.3 to 1.5)
Myeloid leukaemia† 7/<1 14.8 (6.0 to 30.6) 8/3 2.6 (1.1 to 5.2) 2/3 0.8 (0.1 to 2.7)
Hodgkin’s lymphoma‡ 8/<1 60.8 (26.2 to 120) 2/1 1.4 (0.2 to 5.0) 6/8 0.7 (0.3 to 1.5)
Non-Hodgkin’s lymphoma§ 5/<1 15.9 (5.2 to 37.2) 8/3 2.7 (1.2 to 5.3) 11/6 1.7 (0.9 to 3.0)
Brain¶ 8/2 4.4 (1.9 to 8.7) 23/14 1.7 (1.1 to 2.5) 30/20 1.5 (1.0 to 2.2)
Some of the most frequent subtypes of cancer were as follows:
*42 of 50 children had precursor cell lymphoblastic leukaemia, not otherwise specified.
†10 of  17 children had acute myeloid leukaemia, not otherwise specified. 
‡10 of 16 children had nodular sclerosis classical Hodgkin’s  lymphoma.
§5 of 24 children had diffuse large B cell, not otherwise specified; 5 had mature T-cell lymphoma, not otherwise specified; 4 had Burkitt 
lymphoma, not otherwise specified and 4 had anaplastic large cell lymphoma.
¶15 of 61 children had glioblastoma; 8 had medulloblastoma, not otherwise specified, and 28 had other or unspecified brain cancer.
 SIR, standardised incidence ratio.
cohort (see the online supplementary appendix 
for specification of aetiology), while the agent was 
unspecified for 64% of the children. Among the 
children, 8733 (10%) had a congenital malforma-
tion (table 1), including 489 children with Down 
syndrome. The prevalence of immune deficiencies 
recorded in the DNPR at the time of pneumonia diag-
nosis was low (n=137). The majority had one or no 
previous hospitalisations, while 25% had two or more 
previous hospitalisations with a minimum duration of 
3 days.
risk of leukaemia, lymphoma and brain cancer
A total of 168 cancers were diagnosed during follow-up 
(826 281 person-years), including 37 diagnosed with 
cancer within 1 month, adding up to 43 cancers within 
the first 6 months following the pneumonia episode. 
The most frequent subtypes of cancer are provided in 
table 2.
The absolute risks of leukaemia, lymphoma and brain 
cancer were all low, combined it reached 0.05% at 
6 months and 0.14% at 5 years.
During complete follow-up, the combined SIR of 
leukaemia, lymphoma and brain cancer was increased 
by almost twofold (table 1). The SIRs were substan-
tially increased during the first 6 months of follow-up: 
6.2 (95% CI 3.5 to  10.3) for lymphoid leukaemia, 
14.8 (95% CI 6.0 to  30.6) for myeloid leukaemia, 60.8 
(95% CI 26.2 to 120) for Hodgkin’s lymphoma, 15.9 
(95% CI 5.2 to  37.2) for non-Hodgkin’s lymphoma 
and 4.4 (95% CI 1.9 to 8.7) for brain cancer (table 2). 
The increased risk of lymphoid leukaemia, myeloid 
leukaemia and non-Hodgkin’s lymphoma persisted up 
to 5 years after a hospital pneumonia diagnosis. Beyond 
5 years of follow-up, more children than expected were 
diagnosed with non-Hodgkin’s lymphomas and brain 
cancers (table 2).
The stratified analyses for the overall cancer occurrence 
showed slightly higher SIRs among girls than among 
boys. Children up to 14 years of age had an approximately 
twofold increased SIR, whereas teenagers aged 15–17 
years had a fourfold increased SIR (table 1). The SIR 
increased over time from 1.2-fold increased during 
1994–1998 to 2.5-fold increased during 2009–2013. 
Children with imaging-confirmed diagnoses had a SIR 
of almost three, whereas children without confirmed 
diagnosis had a SIR around the unity (table 1). Though 
numbers were low, children diagnosed with immune 
deficiencies or congenital malformations had higher 
SIRs for cancer than children without these condi-
tions. However, importantly the increased risk was 
not confined to children with such known conditions. 
While the overall SIR for children without previous 
hospitalisations was around unity, the SIR for children 
with one or two visits was almost twofold increased, and 
the SIR for those with three or more visits was threefold 
increased (table 1).
DIscussIOn
We found that a hospital-based diagnosis of pneumonia 
was a rare presentation of occult childhood cancer. The 
children hospitalised with pneumonia had a higher 
short-term incidence of leukaemia, lymphoma and brain 
cancer than expected and had a persistently increased 
risk of non-Hodgkin’s lymphoma and brain cancer more 
than 5 years after the pneumonia. However, the absolute 
risk of cancer was low, which accords with the low inci-
dence of childhood malignancies.
The association between hospital-based diagnoses of 
common infections and subsequent cancer occurrence 
are conflicting. A Danish population-based study found 
no overall association with previous admission for infec-
tious diseases and risk of leukaemia. However, the study 
did not explore risks according to type of infection.3 
By contrast, a French case–control study indicated that 
common infections occurring in children during the first 
year of life potentially were associated with decreased risk 
of leukaemia, whereas children with infections requiring 
group.bmj.com on February 1, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
4 Søgaard KK, et al. BMJ Open 2017;7:e019860. doi:10.1136/bmjopen-2017-019860
Open Access 
hospitalisation could be at increased risk of a leukaemia 
diagnosis.4 Supporting the latter finding, a Taiwan case–
control study found that a hospital diagnosis of pneu-
monia was associated with subsequent increased risk of 
myeloid leukaemia diagnosis.5 We found that children 
presenting with pneumonia had a subsequent higher 
occurrence of leukaemia, lymphoma and brain cancer 
than other Danish children.
The strengths of our study include its population-based 
design in the setting of a uniformly organised healthcare 
system. In agreement with the overall completeness of chest 
X-ray records in the DNPR,10 we found that the majority of 
diagnoses were based on imaging procedures. In addition, 
cancer diagnoses in the DCR have high completeness and 
validity.9 We included children with immune deficiency and 
congenital malformations, which are known to have higher 
incidence of both pneumonia and cancer. However, in the 
analyses excluding these children, the results remained 
unchanged. Our study also had potential limitations. We 
could not separate the order of the diagnoses among those 
diagnosed with pneumonia and cancer during same admis-
sion nor identify children in whom lymphoma was initially 
falsely interpreted as pneumonia. We used hospital-based 
diagnosis of pneumonia within the setting of a developed 
country. Accordingly, generalisability may be transferable 
to other industrial Western societies but not necessarily to 
undeveloped countries neither to pneumonia diagnosis in 
the general practice setting.
There are several possible explanations for our findings. 
Chest X-rays and blood tests performed as part of workup 
for pneumonia may have yielded findings suspicious of 
cancer leading on to further examinations. In addition, 
lymphoma with a mediastinal mass or with lung involve-
ment may have initially been misdiagnosed as pneumonia 
in some cases. Children with cancer have higher GP consul-
tation rates than controls in the year preceding the cancer 
diagnosis.11 In agreement, we found higher SIRs for chil-
dren with previous hospital contacts, thus pneumonia 
may not have been the first clinical disease in all children. 
Although increased diagnostic effort may partially explain 
the higher short-term occurrence of cancer, it is unlikely to 
explain the increased risk of lymphoma and brain cancer 
observed more than 5 years after pneumonia. There is an 
ongoing debate on whether or not infectious diseases in 
children may modulate the child’s immune response poten-
tially leading to decreased or increased risk of cancer.12–14 
We did not attempt to address or clarify this hypothesis as 
our data would not allow us to do so. However, we speculate 
if the associations demonstrated may be due to cancer-re-
lated impairment of the immune system, making a child 
more vulnerable to severe infections such as pneumonia. 
In children with an aggressive type of cancer, the infection 
may lead on to cancer diagnosis, whereas in children with 
a more indolent cancer, the infection occurs in the preclin-
ical phase.1
Based on the low absolute cancer risks observed, our 
findings do not warrant a change in the workup of children 
diagnosed with pneumonia during a hospital admission.
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